Approvals & regulatory · first seen 14h ago, updated 14h ago
Kyverna says long-term data bolster FDA submission for rare autoimmune CAR-T
Kyverna Therapeutics touted positive one-year results on Thursday in patients with a rare autoimmune disorder called stiff person syndrome. The condition affects about 6,000 patients in the US, causing painful muscle spasms and stiffness. K…
Summary from Endpoints News.